Serum total IGF-I, free IGF-I, and IGFBP-1 levels in an elderly population: Relation to cardiovascular risk factors and disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 2, 1998, Pages 277-282

  Janssen, J A M J L ^a,c   Stolk, R P ^b   Pols, H A P ^a   Grobbee, D E ^a,b   Lamberts, S W J ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Atherosclerosis; Cardiovascular risk factors; Elderly; Free IGF I; IGFBP 1

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADULT; AGED; AGING; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CORONARY ARTERY DISEASE; FEMALE; HUMAN; INSULIN BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031862937     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.2.277     Document Type: Article

References (16)

1. Ferns GAA, Morani AS, Anggard EE. The insulin-like growth factors: their putative role in atherogenesis. Artery. 1991;18:197-225.
2. Delafontaine P, Bernstein KE, Alexander RW. Insulin-like growth factor I gene expression in vascular cells. Hypertension. 1991:17:693-699.
3. Banskota NK, Taub R, Zellner K, Olsen P, King GL. Characterization of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGF-I. Diabetes. 1989;38:123-129.
4. Grant MB, Wargovich TJ, Ellis EA, Caballero S, Mansour M, Pepine CJ. Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostarin analogues in human coronary smooth muscle cells: a potential treatment for restenosis. Circulation. 1994; 89:1511-1517.
5. Tsukahara H, Gordienko DV, Tonshoff B, Gelato MC, Goligorsky MS. Direct demonstration of insulin-like growth factor-I induced nitric oxide by endothelial cells. Kidney Int. 1994;45:598-604.
6. Ørskov H, Weeke J, Frystyk J, Kaal A, Nielsen S, Skjaerbaek C, Christiansen JS, Moller N, Jorgensen JOL. Growth hormone determination in serum from patients with growth disorders. In: Juul A, Jorgensen JOL, eds. Growth Hormone in Adults. Cambridge, UK: Cambridge University Press; 1996:109-121.
7. Frystyk J, Skjaerbaek C, Dinesen B, Orskov H. Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett. 1994;384:185-191.
8. Lee PDK, Powell D, Baker B, Liu F, Mathew G, Levitsky I, Gutierrez OD, Hintz RL. Characterization of a direct, non-extraction immunoradiometric assay for free IGF-I. In: Program and abstracts of the 76th annual meeting of the Endocrine Society; June 15-18, 1994:435 Anaheim, Calif. Abstract.
9. Lowe WL. Biological actions of the insulin-like growth factors. In: LeRoith D, ed. Insulin-like Growth Factors: Molecular and Cellular Aspects. Boca Raton, Fla: CRC Press; 1991:49-85.
10. Holly JMP. Insulin-like growth factor binding proteins in diabetic and nondiabetic states. In: Flyvbjerg A, Orskov H, Alberti KGMM, eds. Growth Hormone and Insulin-like Growth Factor I in Human and Experimental Diabetes. New York, NY: John Wiley & Sons, Inc; 1993:47-76.
11. Hall K, Brismar K, Hilding A, Lindgren B. Insulin-like growth factor-binding protein-1, a marker of insulin production. Clin Pediatr Endocrinol. 1993;2(suppl 2):51-55.
12. Bar RS, Clemmons DR, Boes M, Busby WH, Booth BA, Dake BL, Sandra A. Transcapillary permeability and subendothelial distribution of endothelial and amniotic fluid insulin-like growth factor binding proteins in the heart. Endocrinology. 1990;127:1078-1086.
13. Lee PDK, Conover CA, Powell DR. Regulation and function of insulin-like growth factor-binding protein-1. Proc Soc Exp Biol Med. 1993; 204:4-29.
14. Blum WF, Jenne EW, Reppin F, Kietzmann K, Ranke MB, Bierich JR. Insulin-like growth factor I (IGF-I) binding protein complex is a better mitogen than free IGF-I. Endocrinology. 1989;125:766-772.
15. Hofman A, Grobbee DE, de Jong PTVM, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol. 1991;7:403-422.
16. Van Bemmel JH, Kors JA, van Herpen G. Methodology for the Modular Electrocardiogram Analysis System (MEANS). Methods Inf Med. 1990;29: 346-353.